Matches in Library of Congress for { <http://lccn.loc.gov/2012277161> ?p ?o. }
Showing items 1 to 28 of
28
with 100 items per page.
- 2012277161 contributor B12486266.
- 2012277161 created "2012.".
- 2012277161 date "2012".
- 2012277161 date "2012.".
- 2012277161 dateCopyrighted "2012.".
- 2012277161 description "Includes bibliographical references and index.".
- 2012277161 description "Vertical pathway targeting in cancer therapy -- Histone deacetylases (HDACs) as mediators of resistance to apoptosis in melanoma and as targets for combination therapy with selective BRAF inhibitors -- Targeting the tumor stroma as a novel treatment strategy for breast cancer: shifting from the neoplastic cell-centric to a stroma-centric paradigm -- Targeting the metabolic microenvironment of tumors -- Targeted therapy for brain metastases -- Emerging strategies for targeting cell adhesion in multiple myeloma -- Targeting notch signaling for cancer therapeutic intervention -- Stem-like cells and therapy resistance in squamous cell carcinomas -- Targeting the tumor stroma as a novel therapeutic approach for prostate cancer -- Resistance to chemotherapy: short-term drug tolerance and stem cell-like subpopulations -- Intratumoral heterogeneity as a therapy resistance mechanism: role of melanoma subpopulations -- Chemoprevention of melanoma -- Whole genome and exome sequencing of melanoma: a step toward personalized targeted therapy -- Targeted therapy for gastric adenocarcinoma -- HSP90 inhibitors for cancer therapy and overcoming drug resistance -- Apoptosis in targeted therapy responses: the role of BIM.".
- 2012277161 extent "xviii, 558 p. :".
- 2012277161 identifier "0123979277 (hbk.)".
- 2012277161 identifier "9780123979278 (hbk.)".
- 2012277161 isPartOf "Advances in pharmacology ( San Diego, Calif.) ; 65".
- 2012277161 isPartOf "Advances in pharmacology (San Diego, Calif.) ; 65. 1054-3589".
- 2012277161 issued "2012".
- 2012277161 issued "2012.".
- 2012277161 language "eng".
- 2012277161 publisher "Amsterdam ; Boston : Academic Press,".
- 2012277161 subject "616.99406 23".
- 2012277161 subject "Cancer Treatment.".
- 2012277161 subject "Individualized Medicine methods.".
- 2012277161 subject "Molecular Targeted Therapy methods.".
- 2012277161 subject "Neoplasms genetics.".
- 2012277161 subject "Neoplasms therapy.".
- 2012277161 subject "Pharmacology.".
- 2012277161 subject "RC270.8 .C864 2012".
- 2012277161 subject "Targeted Gene Repair methods.".
- 2012277161 tableOfContents "Vertical pathway targeting in cancer therapy -- Histone deacetylases (HDACs) as mediators of resistance to apoptosis in melanoma and as targets for combination therapy with selective BRAF inhibitors -- Targeting the tumor stroma as a novel treatment strategy for breast cancer: shifting from the neoplastic cell-centric to a stroma-centric paradigm -- Targeting the metabolic microenvironment of tumors -- Targeted therapy for brain metastases -- Emerging strategies for targeting cell adhesion in multiple myeloma -- Targeting notch signaling for cancer therapeutic intervention -- Stem-like cells and therapy resistance in squamous cell carcinomas -- Targeting the tumor stroma as a novel therapeutic approach for prostate cancer -- Resistance to chemotherapy: short-term drug tolerance and stem cell-like subpopulations -- Intratumoral heterogeneity as a therapy resistance mechanism: role of melanoma subpopulations -- Chemoprevention of melanoma -- Whole genome and exome sequencing of melanoma: a step toward personalized targeted therapy -- Targeted therapy for gastric adenocarcinoma -- HSP90 inhibitors for cancer therapy and overcoming drug resistance -- Apoptosis in targeted therapy responses: the role of BIM.".
- 2012277161 title "Current challenges in personalized cancer medicine / edited by Keiran S.M. Smalley.".
- 2012277161 type "text".